Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Passacquale, Gabriella ^a   Vamadevan, Padman ^a   Pereira, Luis ^a   Hamid, Colleen ^a   Corrigall, Valerie ^a   Ferro, Albert ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; ACETYLSALICYLIC ACID; BLOCKING ANTIBODY; C REACTIVE PROTEIN; CD14 ANTIGEN; CD16 ANTIGEN; CYCLOOXYGENASE 2; DIPEPTIDYL PEPTIDASE IV; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; P SELECTIN GLYCOPROTEIN LIGAND 1; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 2; PROTEIN CD26P; UNCLASSIFIED DRUG; FC RECEPTOR; PROSTAGLANDIN E2; PTGS2 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD FLOW; CELL ADHESION; CELL INTERACTION; CELL ISOLATION; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLUENZA VACCINATION; MALE; MONOCYTE; PHENOTYPE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; UPREGULATION; BIOSYNTHESIS; CELL AGGREGATION; CELL COMMUNICATION; CELL MOTION; DRUG EFFECT; IMMUNIZATION; IMMUNOLOGY; INFLAMMATION; INFLUENZA; METABOLISM; PATHOLOGY; THROMBOCYTE; THROMBOCYTE ADHESIVENESS;

ADULT; ANTIGENS, CD14; BLOOD PLATELETS; CELL AGGREGATION; CELL COMMUNICATION; CELL MOVEMENT; CULTURE MEDIA, CONDITIONED; CYCLOOXYGENASE 2; DINOPROSTONE; ENDOTHELIAL CELLS; FEMALE; HUMANS; IMMUNIZATION; INFLAMMATION; INFLUENZA, HUMAN; MALE; MONOCYTES; PHENOTYPE; PLATELET ACTIVATION; PLATELET ADHESIVENESS; RECEPTORS, IGG;

EID: 80053989952     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025595     Document Type: Article

References (25)

1. Mickelson JK, Lakkis NM, Villarreal-Levy G, Hughes BJ, Smith CW, (1996) Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? J Am Coll Cardiol 28 (2): 345-353.
2. Michelson D, Barnard MR, Krueger LA, Valeri CR, Furman MI, (2001) Circulating monocyte-platelet aggregates are a most sensitive marker of in vivo platelet activation than platelet P-selectin: studies in baboons, human coronary intervention, and human myocardial nfarction. Circulation 104: 1533-1537.
3. Htun P, Fateh-Moghadam S, Tomandl B, Handschu R, Klinger K, et al. (2006) Course of Platelet Activation and Platelet-Leukocyte Interaction in cerebrovascular ischemia. Stroke 37: 2283-2287.
4. Smout J, Dyker A, Cleanthis M, Ford G, Kesteven P, et al. (2009) Platelet function following acute cerebral ischemia. Angiology 60 (3): 362-369.
5. Gkaliagkousi E, Corrigall V, Becker S, de Winter P, Shah A, et al. (2009) Decreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension. Eur Heart J 30 (24): 3048-3054.
6. Harding SA, Sommerfield AJ, Sarma J, Twomey PJ, Newby DE, et al. (2004) Increased CD40 ligand and platelet-monocyte aggregates in patients with type 1diabetes mellitus. Atherosclerosis 176: 321-325.
7. Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ, (2001) Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol 115 (2): 451-459.
8. Weyrich AS, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA, (1995) Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-α secretion. Signal integration and NF-kB translocation. J Clin Invest 95: 2297-2303.
9. Weyrich AS, Elstad MR, McEver RP, McIntyre TM, Moore KL, et al. (1996) Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 97: 1525-1534.
10. Dixon DA, Tolley ND, Bemis-Standoli K, Martinez ML, Weyrich AS, et al. (2006) Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling. J Clin Invest 116: 2727-2738.
11. da Costa Martins PA, van Gils JM, Mol A, Hordijk PL, Zwaginga JJ, (2006) Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of beta1 and beta2 integrins. J Leukoc Biol 79 (3): 499-507.
12. Weber C, Belge KU, von Hundelshausen P, Draude G, Steppich B, et al. (2000) Differential chemokine receptor expression and function in human monocyte subpopulations. J Leukoc Biol 67 (5): 699-704.
13. Belge KU, Dayyani F, Horelt A, Siedlar M, Frankenberger M, et al. (2002) The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol 168: 3536-3542.
14. Posthouwer D, Voorbij HAM, Grobbee DE, Numans ME, van der Bom JG, (2004) Influenza and pneumococcal vaccination as a model to assess C-reactive protein response to mild inflammation. Vaccine 23: 362-365.
15. Cipollone F, Rocca B, Patrono C, (2004) Cyclooxygenase-2 Expression and Inhibition in Atherothrombosis. Arterioscler Thromb Vasc Biol 24: 246-255.
16. Ammon C, Kreutz M, Rehli M, Krause SW, Andreesen R, (1998) Platelets induce monocyte differentiation in serum-free coculture. J Leukoc Biol 63: 469-476.
17. Penglis PS, Cleland LG, Demasi M, Caughey GE, James MJ, (2000) Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitors. J Immunol 165: 1605-1611.
18. Harizi H, Juzan M, Pitard V, Moreau JF, Gualde N, (2002) Cyclooxygenase-2-Issued Prostaglandin E2 Enhances the Production of Endogenous IL-10, Which Down-Regulates Dendritic Cell Functions. J Immunol 168: 2255-2263.
19. Kubo N, Boisvert WA, Ballantyne CM, Curtiss LK, (2000) Leukocyte CD11b expression is not essential for the development of atherosclerosis in mice. J Lipid Res 41: 1060-1066.
20. Wu H, Gower RM, Wang H, Perrard XY, Ma R, et al. (2009) Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia. Circulation 119 (20): 2708-2717.
21. Barton GM, Medzhitov R, (2002) Toll-like receptor and their ligands. Curr Top Microbiol Immunol 270: 81-92.
22. Zhang G, Ghosh S, (2001) Toll-like receptor-mediated NK-kB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest 107: 13-19.
23. Kato M, Nishida S, Kitasato H, Sakata N, Kawai S, (2001) Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes. J Pharm Pharmacol 53 (12): 1679-1685.
24. Meja KK, Barnes PJ, Giembycz MA, (1997) Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation. Br J Pharmacol 122 (1): 149-157.
25. Jaffe EA, Nachman RL, Becker CG, Minick CR, (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52: 2745-2756.